Buildora
Navigate PPB, NAFDAC, SAHPRA, and Ghana FDA in minutes. Buildora maps recognition pathways, reliance frameworks, and market entry timelines across African regulatory jurisdictions instantly.
The Problem Buildora Solves
Navigating African pharmaceutical regulations today means hunting through PDFs, emailing regulators, and hoping you haven't missed something. One PPB guideline links to NAFDAC's recognition pathway, which references Ghana FDA's reliance procedures. Getting from "what's the fastest route to Kenya?" to "submit here, use this pathway, expect 18 months" takes weeks.
Buildora cuts that to minutes.
What Buildora Does
An interactive lookup tool that maps regulatory pathways, recognition routes, and approval timelines across four major African markets.
Recognition Pathways
See which countries recognize each other's approvals. Use PPB approval as leverage for SAHPRA. Use EAC joint assessment to cover three countries at once.
Reliance Frameworks
Understand exactly what each regulator will accept as evidence of prior approval elsewhere. Which PV systems does NAFDAC recognize? What manufacturing data does Ghana FDA require?
Timeline Estimates
Get realistic approval timelines for each route—traditional assessment, reliance pathway, joint assessment. Based on actual approval data, not guesses.
Regulatory Contacts
Know who to contact at each regulator for specific issues. Direct phone numbers, email contacts, and submission addresses updated quarterly.
Documentation Guides
Downloadable checklists of exactly what each regulator requires. Quality overall summary depth. PV plan format. Manufacturing data specificity.
Cost Modeling
Calculate total regulatory fees across different market entry scenarios. Three countries via reliance vs. independent assessment? See the cost difference instantly.
Who Uses Buildora
Buildora is built for anyone navigating African pharmaceutical markets.
Regulatory Affairs Teams
Plan your market entry strategy in hours instead of weeks. Instead of emailing RAPSK contacts asking "what's PPB's recognition pathway?", you look it up. You know exactly what NAFDAC will accept and how long it takes. You baseline your timelines accurately.
Manufacturers Planning Entry
Deciding between Kenya, Nigeria, or Ghana? Buildora shows you approval timelines, regulatory complexity, manufacturing data requirements, and cost for each route. You make an informed decision about where to enter first.
Business Development Teams
Your potential partner in India is asking about entering East Africa. You pull up Buildora, run a quick scenario analysis, and tell them: "PPB in Kenya is 14-18 months. SAHPRA in South Africa prefers local manufacturing. NAFDAC in Nigeria requires local clinical data in some cases." You sound like a regional expert.
Consultants & Advisors
You're advising a company on African market strategy. Buildora gives you current, structured data on regulatory timelines and recognition pathways. Your recommendations are grounded in regulatory reality, not assumptions.
Current Coverage
Buildora v1.0 covers human pharmaceuticals and medical devices across four major regulatory jurisdictions.
PPB (Kenya)
Recognition pathways, joint assessment routes, approval timelines
NAFDAC (Nigeria)
Recognition of PPB and SAHPRA approvals, local data requirements
SAHPRA (South Africa)
Recognition pathways, manufacturing requirements, approval timelines
Ghana FDA
Approval timelines, reliance procedures, EAC alignment
Roadmap: Future Markets
We're expanding to EACCMA (East African Common Market) framework, ECOWAS (West African harmonization), and SADC (Southern African coordination). Target: 15 African jurisdictions by end of 2027.
How Buildora Saves Time & Money
Real numbers from our user testing.
Scenario 1: Market Entry Planning
Without Buildora: A regulatory team spends 3-4 weeks researching recognition pathways, emailing regulators, reading guidelines, and building a market entry timeline. Cost: 200+ hours of RA time.
With Buildora: Same regulatory team runs the scenario in 2 hours. They get recognition pathways, approval timelines, documentation requirements, and regulatory contacts instantly. Savings: 90+ hours of RA time. Value at loaded cost ($75/hr): $6,750.
Scenario 2: Registration Strategy
Without Buildora: A manufacturer plans to enter Kenya independently. They don't know about EAC joint assessment pathway. They submit five separate applications to PPB instead of grouping two under joint assessment. Extra PPB statutory fees: $4,000. Extra timeline: 4 months.
With Buildora: Same manufacturer looks up "multiple products, PPB" and sees joint assessment option immediately. They group optimally, save statutory fees, and launch 4 months earlier. Earlier revenue realization: conservatively $150K+ depending on product type.
Buildora: Q4 2026
Early access launching October 2026. The full tool will be available via a simple web interface—no subscription, no login friction. Query a market, get an answer in seconds.
Request Early AccessWhy PharmaMED Built This
We've helped 400+ clients navigate African regulatory frameworks. The same questions come up repeatedly: "What's the fastest route to Kenya?" "Does NAFDAC recognize PPB?" "How long does SAHPRA take?" Every company wastes weeks researching answers that already exist—they're just scattered across PDFs and regulators' heads.
Buildora consolidates that institutional knowledge into one tool. It's built on actual approval data, regulatory guidelines, and our direct relationships with RAPSK, PPB, NAFDAC, and SAHPRA. As regulations change and new pathways open, we update Buildora quarterly.
This is part of our broader RegTech vision: transforming regulatory affairs from a compliance burden into a strategic advantage through technology.
Partner With PharmaMED
Buildora is one part of our regulatory strategy service. Most clients use it alongside our strategic consulting and execution services—using Buildora for rapid pathway analysis, then engaging our team for dossier preparation and submission coordination.
Start a Conversation